원격 환자 모니터링용 인공지능(AI) 시장 : 구성 요소, 기술, 디바이스 유형, 제공 형태, 서비스 유형, 용도, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Artificial Intelligence in Remote Patient Monitoring Market is projected to grow by USD 11.66 billion at a CAGR of 26.47% by 2032.

Artificial intelligence in remote patient monitoring (AI in RPM) is moving connected care from episodic measurement to continuous, data-driven clinical oversight. Adoption is being shaped by a rising chronic disease burden, aging populations, hospital capacity pressure, clinician workforce constraints, and broader use of connected medical devices, wearables, home diagnostics, and virtual care platforms.

The need is measurable: the World Health Organization reports that noncommunicable diseases account for about 41 million deaths annually, or 74% of global deaths, while the U.S. Centers for Disease Control and Prevention states that 6 in 10 U.S. adults live with at least one chronic disease. AI-enabled RPM helps clinicians identify risk signals from real-time and longitudinal data, support earlier intervention, and personalize care pathways across cardiology, diabetes, respiratory disease, maternal health, oncology, rehabilitation, and post-acute monitoring.

Transformative Shifts in the AI-RPM Landscape

The remote patient monitoring landscape is shifting from device-centric data capture to intelligence-led care orchestration. Traditional RPM systems focused on collecting blood pressure, glucose, oxygen saturation, heart rhythm, weight, temperature, sleep, and activity data. The next phase adds machine learning, predictive analytics, natural language processing, computer vision, and edge AI to detect deterioration patterns, prioritize alerts, summarize patient status, and reduce clinician burden.

Three structural shifts are redefining competitive advantage: interoperability with electronic health records, clinically validated algorithms, and reimbursement-aligned virtual care operations. Standards such as HL7 FHIR, expanding broadband and 5G connectivity, cloud-native analytics, and software-as-a-medical-device oversight are making AI-powered RPM more scalable, but success increasingly depends on evidence generation, cybersecurity, explainability, equitable data representation, and integration into clinical workflows.

Cumulative Impact of Artificial Intelligence on RPM

Artificial intelligence has a cumulative impact across the remote patient monitoring value chain. At the patient level, AI supports earlier identification of risk by analyzing longitudinal trends rather than isolated readings. At the provider level, it helps filter high-volume monitoring data, stratify patients by acuity, route actionable alerts to the right care team, and support more consistent follow-up. At the payer and health-system level, it strengthens population health management, avoidable utilization reduction, and value-based care execution.

The impact is strongest when AI models are trained on representative data, validated in real-world settings, monitored after deployment, and governed by clear clinical protocols. Evidence from telehealth and RPM programs shows that remote monitoring can improve chronic disease management when paired with care coordination; AI extends this value by making monitoring more predictive, scalable, and personalized while requiring strong safeguards for bias, privacy, cybersecurity, transparency, and patient safety.

Key Regional Insights for AI-Enabled RPM

North America remains a leading adoption hub for AI in remote patient monitoring due to mature digital health infrastructure, established virtual care reimbursement pathways, FDA oversight for AI-enabled medical devices, and strong participation from health systems, technology developers, payers, and academic medical centers. Europe is advancing through connected care, telemonitoring, digital therapeutics, and privacy-focused deployment under GDPR and the EU Medical Device Regulation, while national health systems increasingly prioritize virtual wards, hospital-at-home models, and home-based chronic care.

Asia-Pacific is one of the most dynamic regions for AI-enabled RPM, supported by large patient populations, rapid smartphone adoption, aging demographics in Japan, South Korea, and China, and digital health expansion in India and Southeast Asia. Latin America is gaining traction as public and private providers use RPM to extend specialist access, particularly in Brazil and Mexico, where chronic disease follow-up and geographic access gaps remain important drivers. The Middle East is investing in smart hospitals, cloud-enabled health records, and national digital health strategies, especially across Gulf economies, while Africa's opportunity is tied to mobile-first models, community health networks, and scalable monitoring for underserved populations despite infrastructure, affordability, and connectivity barriers.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, AI-enabled RPM is being shaped by mobile-first healthcare access, rising chronic disease prevalence, and government-backed digital health initiatives in markets such as Singapore, Indonesia, Thailand, Malaysia, Vietnam, and the Philippines. The GCC is advancing faster in high-acuity virtual care and smart hospital ecosystems, supported by national transformation programs, strong healthcare investment, and demand for remote chronic disease management across diabetes, cardiovascular disease, and post-acute care.

The European Union emphasizes regulated, interoperable, and privacy-preserving deployment, making clinical validation, cross-border data governance, and harmonized digital health standards central to adoption. BRICS economies represent substantial implementation scale because of large populations, expanding middle classes, and growing digital health infrastructure, though adoption varies by reimbursement maturity, public health capacity, and regional connectivity. G7 countries lead in clinical research, reimbursement experimentation, regulatory frameworks, and AI governance, while NATO member states increasingly view secure digital health infrastructure, cybersecurity, and resilient remote care capability as part of broader health-system readiness.

Key Country Insights for AI in Remote Patient Monitoring

The United States leads commercialization through RPM reimbursement, payer-provider partnerships, advanced hospital networks, and FDA-cleared digital health innovation. Canada's adoption is supported by provincial virtual care programs, rural and remote access needs, and chronic disease management priorities, while Mexico and Brazil are expanding connected care to improve specialist reach, hypertension and diabetes follow-up, and continuity of care. In Europe, the United Kingdom is scaling virtual wards and NHS-backed digital pathways; Germany benefits from strong medtech infrastructure and digital health policy momentum; France, Italy, and Spain are advancing telemonitoring through national and regional care models; and Russia's adoption is influenced by domestic digital health modernization and regional access needs.

China is scaling AI-enabled healthcare through hospital digitization, large connected health ecosystems, and chronic disease demand. India combines high population need, expanding telemedicine, smartphone penetration, and cost-sensitive innovation, creating strong long-term potential for AI-assisted RPM. Japan's aging society makes home monitoring, fall risk detection, cardiovascular monitoring, and predictive care highly relevant, while South Korea's advanced connectivity and medical technology ecosystem support rapid deployment. Australia is using remote monitoring to address rural distance, chronic care management, Indigenous health access gaps, and home-based healthcare delivery.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated AI models, workflow integration, and measurable outcomes rather than standalone device deployment. The strongest strategies combine connected sensors, patient engagement tools, triage automation, EHR integration, reimbursement design, remote nursing protocols, and multidisciplinary care teams.

Executives should invest in explainable AI, cybersecurity, regulatory readiness, algorithm monitoring, and health equity safeguards. Partnerships with hospitals, payers, device manufacturers, cloud infrastructure providers, clinical researchers, and validation networks can accelerate adoption. Leaders should also track outcomes such as alert burden, escalation accuracy, adherence, time to intervention, emergency visits, readmissions, clinician time saved, patient activation, and patient satisfaction to prove value at scale.

Research Methodology

This executive summary is developed using a secondary-research framework that synthesizes publicly available evidence from healthcare authorities, regulatory agencies, peer-reviewed literature, digital health policy publications, standards bodies, and industry disclosures. Core inputs include data and guidance from organizations such as the World Health Organization, U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration, OECD, International Telecommunication Union, national health agencies, and recognized clinical and technology standards bodies.

The methodology evaluates market drivers, technology adoption patterns, regulatory conditions, reimbursement dynamics, regional healthcare infrastructure, connectivity readiness, clinical evidence, and competitive implications. Insights are triangulated across multiple credible sources to avoid reliance on single-point claims, with emphasis on verified indicators such as chronic disease prevalence, aging demographics, broadband and mobile access, medical device regulation, AI governance, cybersecurity requirements, and digital health implementation trends.

Conclusion

Artificial intelligence is becoming a defining layer of remote patient monitoring by converting continuous patient data into actionable clinical intelligence. The opportunity is not limited to data capture; it lies in prediction, prioritization, personalization, and scalable care coordination across home, ambulatory, post-acute, and chronic care settings.

As health systems face chronic disease growth, workforce shortages, aging populations, health equity gaps, and cost pressure, AI-enabled RPM offers a practical pathway to shift more care into the home without losing clinical visibility. Organizations that combine evidence-based AI, trusted data governance, interoperable platforms, secure infrastructure, and patient-centered design will be best positioned to lead the next phase of connected healthcare.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Intelligence in Remote Patient Monitoring Market, by Component

• 7.1. Hardware
  • 7.1.1. Connectivity Devices
  • 7.1.2. Monitoring Devices
• 7.2. Services
  • 7.2.1. Managed Services
    • 7.2.1.1. Remote Monitoring
    • 7.2.1.2. Support Services
  • 7.2.2. Professional Services
    • 7.2.2.1. Consulting
    • 7.2.2.2. Integration
    • 7.2.2.3. Training
• 7.3. Software
  • 7.3.1. Analytics Software
  • 7.3.2. Platform Software

8. Artificial Intelligence in Remote Patient Monitoring Market, by Technology

• 8.1. Computer Vision
  • 8.1.1. Image Recognition
  • 8.1.2. Video Analytics
• 8.2. Deep Learning
  • 8.2.1. Convolutional Neural Networks
  • 8.2.2. Recurrent Neural Networks
• 8.3. Machine Learning
  • 8.3.1. Reinforcement Learning
  • 8.3.2. Supervised Learning
  • 8.3.3. Unsupervised Learning
• 8.4. Natural Language Processing
  • 8.4.1. Speech Recognition
  • 8.4.2. Text Analytics

9. Artificial Intelligence in Remote Patient Monitoring Market, by Device Type

• 9.1. Contactless Devices
  • 9.1.1. Camera Based Sensors
  • 9.1.2. Environmental Sensors
  • 9.1.3. Radar Sensors
• 9.2. Wearable Devices
  • 9.2.1. Patches
  • 9.2.2. Smart Garments
  • 9.2.3. Wristbands

10. Artificial Intelligence in Remote Patient Monitoring Market, by Mode Of Delivery

• 10.1. Cloud
• 10.2. On Premise

11. Artificial Intelligence in Remote Patient Monitoring Market, by Service Type

• 11.1. Managed Services
• 11.2. Professional Services

12. Artificial Intelligence in Remote Patient Monitoring Market, by Application

• 12.1. Chronic Disease Management
  • 12.1.1. Cardiac Monitoring
  • 12.1.2. Diabetes Management
  • 12.1.3. Respiratory Monitoring
• 12.2. Elderly Care
  • 12.2.1. Fall Detection
  • 12.2.2. Medication Management
• 12.3. Emergency Alert
  • 12.3.1. Automated Alert
  • 12.3.2. Panic Button
• 12.4. Fitness Monitoring
  • 12.4.1. Activity Tracking
  • 12.4.2. Nutrition Monitoring

13. Artificial Intelligence in Remote Patient Monitoring Market, by End User

• 13.1. Ambulatory Care Settings
• 13.2. Clinics
• 13.3. Home Care Settings
• 13.4. Hospitals

14. Artificial Intelligence in Remote Patient Monitoring Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Artificial Intelligence in Remote Patient Monitoring Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Artificial Intelligence in Remote Patient Monitoring Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. Accuhealth Global Inc
• 18.2. AiCure, LLC
• 18.3. Apexon
• 18.4. Binah.ai Ltd
• 18.5. Biofourmis Inc.
• 18.6. Cardiomo Care, Inc.
• 18.7. ChroniSense Medical, Ltd.
• 18.8. CU-BX Automotive Technologies Ltd.
• 18.9. Current Health Limited
• 18.10. DrKumo Inc.
• 18.11. Ejenta, Inc.
• 18.12. Feebris Ltd.
• 18.13. Gyant.com, Inc.
• 18.14. Huma Therapeutics Limited
• 18.15. iBeat, Inc.
• 18.16. iHealth Labs, Inc.
• 18.17. Implicity
• 18.18. Jorie Healthcare Patners LLC
• 18.19. Myia Labs Inc.
• 18.20. Neteera Technologies Ltd.
• 18.21. Philips Healthcare
• 18.22. Resideo Technologies, Inc
• 18.23. Senseonics Holdings, Inc
• 18.24. Somatix Inc.
• 18.25. Zephyr AI